This NDC is on FDA's drug shortage list (posted Dec 15, 2021)

Reported reason: Other

Product Information

DEPO-MEDROL 80 MG/ML VIAL is a brand product labeled by Pharmacia & Upjohn Company LLC, priced at $11.5329 per ML under NDC 00009347501. Its NADAC has been published 552 times since Nov 28, 2013.

FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DEPO-MEDROL 80 MG/ML VIAL

methylprednisolone acetate
$11.5329per ML

Strength

80 mg/mL

NDC

00009347501

Classification

Brand

Dosage Form

INJECTION, SUSPENSION

Route

INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE

Effective Date

8/19/2026

Active Ingredients

METHYLPREDNISOLONE ACETATE

Approval Type

New Drug (NDA)

FDA Application

NDA011757

FDA Approved

Before 1982

TE Code

AB

On Market Since

5/28/1959

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for DEPO-MEDROL 80 MG/ML VIAL has been published 552 times since Nov 28, 2013, and over the history we have for it it has risen 17.3%. The table below summarizes its recorded NADAC range and movement.

Current price$11.5329 per ML
All-time high$18.7112 (Jul 11, 2018)
All-time low$7.3382 (May 21, 2025)
52-week high$11.5329
52-week low$7.8544
Median price$14.3216
Average price$13.7695
Largest weekly change-39.5% (Apr 17, 2024)
Weeks tracked552
Tracking sinceNov 28, 2013

Price History

1W

+6.0%

1M

+6.0%

3M

+5.2%

6M

+8.7%

1Y

+46.8%

3Y

-37.0%

5Y

-35.0%

All

+17.3%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of DEPO-MEDROL 80 MG/ML VIAL?

The current National Average Drug Acquisition Cost (NADAC) for DEPO-MEDROL 80 MG/ML VIAL, manufactured by Pharmacia & Upjohn Company LLC, is $11.5329 per ML (NDC 00009347501), effective Aug 19, 2026.

How has the price of DEPO-MEDROL 80 MG/ML VIAL changed over time?

Over the history we have for it, the NADAC for DEPO-MEDROL 80 MG/ML VIAL has risen 17.3%. It has been tracked across 552 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for DEPO-MEDROL 80 MG/ML VIAL?

Since Nov 28, 2013, the NADAC for DEPO-MEDROL 80 MG/ML VIAL has ranged from a low of $7.3382 (May 21, 2025) to a high of $18.7112 (Jul 11, 2018), with a median of $14.3216 per ML.

Are there cheaper alternatives to DEPO-MEDROL 80 MG/ML VIAL?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DEPO-MEDROL 400 MG/5 ML VIAL, is $10.8023 per ML — about 6% below DEPO-MEDROL 80 MG/ML VIAL.

Who manufactures DEPO-MEDROL 80 MG/ML VIAL?

DEPO-MEDROL 80 MG/ML VIAL (NDC 00009347501) is labeled by Pharmacia & Upjohn Company LLC, and CMS classifies it as a brand product.

Is DEPO-MEDROL 80 MG/ML VIAL in shortage?

Yes — NDC 00009347501 is currently listed in FDA's drug shortage database (posted Dec 15, 2021). Reported reason: Other.